Moreover, inflammatory markers, such as C-reactive protein (CRP) [23], interleukin-6 (IL-6) [24], and tumor necrosis factor-alpha (TNF-α) [25], are elevated in CRC patients and correlated with tumor aggressiveness and poor prognosis. This evidence concerns the gene CRP and colorectal carcinoma.